← back to search

Tanja Poth

Heidelberg University · DE
Area of research
Epidemiology · Immunology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, interferon and immune responses, Biochemical effects in animals, and Pancreatic and Hepatic Oncology Research.
h-index
17
citations
905
works
80
NIH funding
primary concept
email

Recent publications

Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships
Nature Biomedical Engineering 2025cited by 4position: middledoi
RAGE is a key regulator of ductular reaction-mediated fibrosis during cholestasis
EMBO Reports 2025cited by 1position: middledoi
The cycling and aging mouse female reproductive tract at single-cell resolution
Cell 2024cited by 106position: middledoi
Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells
Gastroenterology 2024cited by 10position: middledoi
Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication
Cellular and Molecular Life Sciences 2024cited by 9position: middledoi
Proteomic profiling reveals CEACAM6 function in driving gallbladder cancer aggressiveness through integrin receptor, PRKCD and AKT/ERK signaling
Cell Death and Disease 2024cited by 8position: middledoi
Integrated combinatorial functional genomics and spatial transcriptomics of tumors decodes genotype to phenotype relationships
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 2position: middledoi
Mast cells link immune sensing to antigen-avoidance behaviour
Nature 2023cited by 125position: middledoi
Acute expression of human APOBEC3B in mice results in RNA editing and lethality
Genome biology 2023cited by 21position: middledoi
Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function
Molecular Metabolism 2022cited by 9position: middledoi
Acute expression of human APOBEC3B in mice causes lethality associated with RNA editing
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 5position: middledoi
The function and decline of the female reproductive tract at single-cell resolution
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 4position: middledoi
Acute expression of human APOBEC3B in mice causes lethality associated with RNA editing
Research Square 2022cited by 1position: middledoi
TRAF6 prevents fatal inflammation by homeostatic suppression of MALT1 protease
Science Immunology 2021cited by 32position: middledoi
The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma
Hepatology 2021cited by 20position: middledoi
Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 1position: middledoi
Liver progenitor cells regulate ductular reaction and induce fibrosis upon severe liver injury via RAGE signaling
Zeitschrift für Gastroenterologie 2021cited by 0position: middledoi
The Microarchitecture of Pancreatic Cancer as Measured by Diffusion-Weighted Magnetic Resonance Imaging Is Altered by T Cells with a Tumor Promoting Th17 Phenotype
International Journal of Molecular Sciences 2020cited by 18position: middledoi
Abstract 5728: Liver progenitor cells induces fibrosis via RAGE signaling upon liver injury
Cancer Research 2020cited by 0position: middledoi
Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists
Viruses 2019cited by 43position: middledoi
TAZ-inactivation partly compensates the phenotype caused by YAP knockdown in livers of YAP/TAZ-deficient mice
Zeitschrift für Gastroenterologie 2019cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mathias Heikenwälder · German Cancer Research Center4 papers (2019–2025)Peter Angel · German Cancer Research Center3 papers (2020–2025)Rafail Nikolaos Tasakis · Icahn School of Medicine at Mount Sinai3 papers (2022–2023)Anna Saborowski · Medizinische Hochschule Hannover3 papers (2020–2021)Albrecht Stenzinger · Chirurgische Universitätsklinik Heidelberg3 papers (2022–2023)Uri Ben‐David · Tel Aviv University3 papers (2022–2023)Reuben S. Harris · Howard Hughes Medical Institute3 papers (2022–2023)Aurora De Ponti · German Cancer Research Center3 papers (2020–2025)Rocı́o Sotillo · German Cancer Research Center3 papers (2022–2023)Gisela Gabernet · University of Tübingen3 papers (2020–2025)Alicia Alonso de la Vega · The Francis Crick Institute3 papers (2022–2023)Eli Reuveni · Hebrew University of Jerusalem3 papers (2022–2023)Doris Schneller · German Cancer Research Center3 papers (2020–2025)Kálmán Somogyi · German Cancer Research Center3 papers (2022–2023)Peter Schirmacher · Kliniken Essen-Mitte3 papers (2019–2025)Nuri A. Temiz · The University of Texas at Austin3 papers (2022–2023)Sven Nahnsen · Yale University3 papers (2020–2025)Lio Böse · University Hospital Heidelberg2 papers (2024–2025)Gleb D. Rukhovich · German Cancer Research Center2 papers (2024–2025)Fritjof Lammers · Swiss Ornithological Institute2 papers (2022–2024)